Sign In
to Vote &
Create Storyboards.
 
(American Associates, Ben-Gurion University of the Negev) 'In the future, people who suffer from nighttime AFib may benefit from medications developed to treat people who carry a mutation in this gene,' Prof. Katz says. 'Treating patients based on a genetic understanding of their disease is known as precision medicine.'
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard